Theranostics Health Announces Agreements with Avera Health to Assess and Develop TheraLink® Assay Technology

Theranostics Health, Inc., announced today a series of agreements to expand on current research and commercial collaborations with Avera Health to assess the TheraLink® Assay technologies as a proteomic-based personalized medicine tool in breast cancer, and to help explore its potential utility in a number of other key cancers.

To read more: Avera Health TheraLink® Technology Collaboration